Products
Suppliers
Sourcing Requests

Visitor
Exhibitor
Advertiser
Supplier
Buyer

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

You are here: Home > Industry Insights

Industry Insights

CPHI & PMEC China 2024

CPHI & PMEC China 2024

An Overview to 2023 Pharmaceutical Industry by PharmaSources Experts

An Overview to 2023 Pharmaceutical Industry by PharmaSources Experts

World’s first malaria vaccination programme launched in West Africa

World’s first malaria vaccination programme launched in West Africa

Pharmaceutical Industry in 2024: Flexible Production, Innovative Drugs and Personalized Medicine

Pharmaceutical Industry in 2024: Flexible Production, Innovative Drugs and Personalized Medicine

Hi there, Content Hub is now available! Keep Yourself in Tune with the Latest industry Dynamics

Hi there, Content Hub is now available! Keep Yourself in Tune with the Latest industry Dynamics

Becoming Contracted Authors of PharmaSources

Becoming Contracted Authors of PharmaSources

autoimmune diseases

hidradenitis suppurativa

drug development

What To Expect In The 2024 Pharmaceutical Market

Vitamin E Acetate

what to expect in the 2024 pharma market

Barinjaka vaovao

NIGEL J SMART PHD

Туркменистан

Orelabrutinib: A Novel BTK inhibitor

leachables risk

Туркменистан'"

ТуркменистанXKJD0MLE

Pharma in China >>

Joining Forces with Zai Lab: What is the Remaining Market Potential for Opdivo in China? Yefenghong
March 06, 2024
Bristol Myers Squibb (BMS) recently announced the transfer of sales rights for one of its core products, the PD-1 monoclonal antibody Opdivo (nivolumab), in select provinces within China to the local biotechnology firm Zai Lab Limited (ZLAB).
Becoming Contracted Authors of PharmaSources PharmaSources.com
February 26, 2024
Join PharmaSources.com to share your insights into the pharmaceutical industry with hundreds of industrial KOLs in a league!
Looking at the ADC Territory of Two Industry Pioneers From the DS-8201 Patent Dispute Yefenghong
January 02, 2024
A study by renowned American economist Edwin Mansfield suggests that 60% of new drugs would not be invented without patent protection, highlighting the importance of patent protection in the pharmaceutical industry today.

Pharma Experts >>

WHO's Newest Updates in Pharmaceutical GMP Guidelines Saher Binte Haider
April 23, 2024
GMP is a fundamental concept in pharmaceutical manufacturing and distribution. Poor-quality medicinal products can lead to adverse effects, treatment failure, and even death. Implementing GMP assures that pharmaceutical products are produced with the high

Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology PharmaSources
April 18, 2024
Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article Biotech Newswire
April 10, 2024
Celonic Launches New GS-CHOvolution® Cell Line Expression System Biotech Newswire
April 10, 2024
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT transposon technology.

Products Guide >>

Drug Apocalypse of the Future: Artificial Intelligence Discovers New Antibiotics, Disrupting Traditional Innovations Big Cat of Medical Field
March 11, 2024
At present, the use of artificial intelligence to participate in the discovery and design of new drugs has become a hot track for new drug research and development.
Popular Products and Companies at PharmaSources.com (January 2024) PharmaSources
February 23, 2024
Regulatory Compliance in API Drug Production of Different Countries PharmaSources
January 02, 2024

What companies are developing CNS drugs in China? ChatGTP/PharmaSources
November 08, 2023
Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Advertising Email to: Julia.zhang@imsinoexpo.com

Media Cooperation Email to: Jennifer.Yang@imsinoexpo.com
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Subscribe Join Us

Note: You can unsubscribe from the alerts at any time.

EZBuy

Livestream & Activity

Conference & Forum

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2024 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight JANUARY 2024

PharmaSources Customer Service